Today we have Dr. Anne Peters on the podcast telling us all about Continuous Glucose Monitoring for Patients.

Dr. Holly Wyatt's love for research began when she was just a child. She credits her father, an electrical engineer, with sparking her curiosity for the sciences and putting her on the path to becoming the clinical scientist she is today. Her personal challenges with “stopping the yo-yo” of dieting drove her to seek answers about metabolism and how the body and mind work together when it comes to losing weight and keeping it off forever. You don't want to miss her tips and tricks for treating patients with obesity in this podcast episode.

Recent data and the FDA approval of tirzepatide have generated a lot excitement in the medical community about the role of this agent in the treatment of type 2 diabetes and obesity. In this podcast, CMHC Co-Chair Dr. Anne Peters, Professor of Medicine at the University of Southern California in LA, discusses the clinical implications of this agent and its potential role now and going forward.

Tune in to listen to Joe Pizzorno, ND, one of the world’s leading experts on science-based natural and integrative medicine, talk about the impact of environmental toxins in the development and exacerbation of cardiometabolic diseases, as well as what clinicians and patients can do to lower their burden on health and outcomes. Also, please don’t forget to rate, subscribe/follow, and leave us a 5-star review!

Listen as Dr. Filomena Trindade, a physician, teacher, author, and internationally recognized speaker who focuses on functional medicine and a holistic preventative approach to care, discusses the diabetes questions you’ll want to be asking your patients. You don’t want to miss what she has to say in this part two podcast special! Also, don’t forget to rate, subscribe or follow, and leave a 5-star review!

Listen in to our part two of our conversation with Linda Shiue, MD, an internist and professionally trained chef in the department of Adult and Family Medicine and the Director of Culinary Medicine at Kaiser Permanente San Francisco.

The American Diabetes Association (ADA) Standards of Care is an important guideline that sets the tone about diabetes treatment in the U.S. Tune in to listen to Anne L. Peters, MD, Professor of Medicine at the University of Southern California and co-author of the ADA Standards of Care, discuss important updates in the 2022 guidance.

Dr. Filomena Trindade, a physician, teacher, author, and internationally recognized speaker who focuses on functional medicine and a holistic preventative approach to care discusses the potential reversal of Type 2 diabetes. You don’t want to miss what she has to say! Also, don’t forget to rate, subscribe or follow, and leave a 5-star review!

Tune in to listen to Kenneth Cusi, MD talk about the increasing burden of NAFLD and NASH, important considerations for screening and diagnosis that clinicians in the community should be aware of, as well as perspectives about current and emerging treatments.

Listen in as Dr. George Bakris, the Director of the Comprehensive Hypertension Center and kidney disease specialist, discusses the latest cardiometabolic concepts and new ways to help create helpful healing plans for patients.

Listen in as Fatima Stanford, MD, Associate Professor of Medicine and Pediatrics, as well as Equity Director at Massachusetts General Hospital Endocrine Division, shares some practical pearls about addressing disparities in the management of obesity.

Listen in as Dr. Mark Houston, the Director of the Hypertension Institute – tripled boarded in hypertension as an American Society of Hypertension specialist, a Fellow of the American Society of Hypertension, Internal Medicine, and Anti-aging medicine discusses the emerging strategies in cardiometabolic medicine.

Despite therapeutic advances, the cardiometabolic disease burden remains disproportionally high in patients from racial and ethnic populations. The reasons for these disparities are complex and underlined by social determinants of health and limited access to appropriate healthcare, among other factors. During this webinar, Dr. Keith C. Ferdinand, MD, hosted a panel with key opinion leaders to discuss the current state of these disparities as well as strategies to better help close these gaps going forward.

Tune in to hear Javed Butler, MD, renowned heart failure (HF) specialist and the principal investigator of several major HF trials, discuss the evolving paradigms of HF care, including the role of SGLT-2 inhibitors as part of foundational therapy, as

Listen in to our conversation with renowned nephrologist and long-term CMHC faculty Mathew R. Weir, MD, who is Professor of Medicine and Division Head of Nephrology at University of Maryland School of Medicine. In this podcast, Dr. Weir covers the exciting new developments in the management of CKD, including SGLT-2 inhibitors and beyond, as well as practical pearls for better adopting these advances to patient care.

Listen in to our conversation with Linda Shiue, MD, an internist and professionally trained chef in the department of Adult and Family Medicine and the Director of Culinary Medicine at Kaiser Permanente San Francisco, and the author of the cookbook “Spicebox Kitchen: Eat Well and Be Healthy with globally inspired, vegetable-forward recipes”. In the podcast, she shares her unique insights on food as medicine, as well as some practical advice on how to better address nutrition in clinical practice.

Listen in as Keith C. Ferdinand, MD, professor of medicine and Gerald S. Berenson Endowed Chair in Preventive Cardiology at the Tulane University School of Medicine and the Tulane Heart and Vascular Institute in New Orleans, Louisiana shares his insight on ethnic & racial disparities in cardiometabolic health. Dr. Ferdinand has dedicated his career to improving these disparities, and was recently named CMHC’s Educational Planning Advisor for Ethnic & Racial Disparities in Cardiometabolic Health.

Listen in as Dr. Irl Hirsch, Professor of Medicine and Diabetes Treatment and Teaching Chair at the University of Washington Medical Center in Seattle, WA., presents an intriguing topic, that of new-onset diabetes due to COVID-19.

Listen in as Dr. Geoffrey Barnes, Assistant Professor of Medicine, as well as a cardiologist and vascular medicine specialist at the University of Michigan Health System, shares his clinical perspectives on the prevention and management of venous thromboembolism (VTE).

Listen in as Dr. Vanita Aroda, Director of Diabetes Clinical Research at the Brigham and Women’s Hospital in Boston and faculty at Harvard Medical School, covers the ever-changing landscape and paradigm shifts in the management of patients with type 2 diabetes.

Listen in as Dr. Adam DeVore, cardiologist and Associate Professor of Medicine at Duke University School of Medicine in Durham, North Carolina, shares results from the CONNECT-HF trial.

Dr. Sarah Hallberg is a nationally and internationally recognized expert in the field of carbohydrate restriction for type 2 diabetes, and part of the largest and longest trial to date in this field. In this interview Dr. Hallberg discusses the evidence behind ketogenic/low carb diets in reducing cardiometabolic risk and much more.

Dr. Carl Lavie, Professor of Medicine and Medical Director of Cardiac Rehabilitation and Prevention, as well as Director of Stress Testing Laboratory at John Ochsner Heart and Vascular Institute in New Orleans, LA discusses the impacts of COVID-19 in obesity management.

Dr. Louis Aronne, Professor of Metabolic Research and Medical Director of the Comprehensive Weight Control Center at Weill Cornell Medicine in New York discuss the evolving landscape of obesity management.

Listen in as Dr. Ahmed Soliman, Associate Medical Director at Houston Methodist DeBakey Cardiology Associates in Houston, Texas, discusses the role of digital health tools and telemedicine in general, given the impacts of the COVID-19 pandemic.

Listen in as Dr. Jay Shubrook, a family physician and diabetes specialist, as well as Professor and Director of Clinical Research at Touro University California in Vallejo California discusses the impact of COVID-19 on diabetes management, as part of a special symposium that will discuss the impact of COVID-19 on cardiometabolic risk

Listen to CMHC’s Senior Planning Committee Member and Spring 2021 Keynote, Dr. Keith C. Ferdinand, Professor of Medicine at the Tulane University School of Medicine in New Orleans, LA, share his insights and clinical pearls regarding the disproportionate burden and disparities during the COVID-19 pandemic.

Dr. Harold Bays, Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center as well as Your Body Goal in Louisville, KY., and Chief Science Officer of Obesity Medicine Association shares his insight on obesity pharmacotherapy, cardiometabolic consequences of obesity as well as how the COVID-19 pandemic impacts obesity management.

Since the month of May is celebrated as Asian Pacific Heritage Month, in this podcast, we had an opportunity to talk with Dr. Leslie Cho, Professor of Medicine and Head of Preventive Cardiology and Rehabilitation at the Cleveland Clinic, Ohio, about the prevalence and management of statin intolerance, particularly in individuals of East Asian descent.

In this podcast, CMHC Chair Robert Eckel, MD, co-president of the American Diabetes Association and Professor of Medicine at the University of Colorado in Aurora, discusses the connections between obesity and COVID-19, as well as some updates on diabetes therapy in patients with diabetes and COVID-19.

In this podcast, CMHC Chair Christie Ballantyne, MD, Professor of Medicine at Baylor College of Medicine, discusses the role of troponins and statins in COVID-19, and how has the pandemic impacted his practice.

In this podcast, Dr. Clyde Yancy, Professor of Medicine at Northwestern, discusses the connections between cardiovascular disease and COVID-19, including cardiac injury, Renin-angiotensin-aldosterone system inhibitors (RAASi) therapy, and more.

Listen to CMHC's Senior Planning Committee Member, Dr. Keith C. Ferdinand, Professor of Medicine at the Tulane University School of Medicine in New Orleans, LA, discuss whether ACEs and ARBs should be withdrawn in patients with COVID-19.

In this podcast, CMHC chair Dr. Anne Peters, Professor of Medicine and Director of Clinical Diabetes Programs at the University of Southern California in Los Angeles, discusses the impact of COVID-19 in patients with diabetes.